By Kamal Choudhury March 26 (Reuters) - Wave Life Sciences shares plunged 58% on Thursday after a higher dose of its experimental obesity drug failed to show a clear improvement at reducing a ...

Wave Life Sciences (WVE) stock plunges as the company interim data from an early-stage trial for WVE-007, its RNA-based ...

Overall, the 25 largest life science employers in Southern California have more than 28,000 employees combined.

Wave Life Sciences (WVE) shares crashed more than 50% on Mardh 26 after the company’s interim Phase 1 data for its obesity ...

Read about the new Biocom Octane partnership. Discover how this collaboration expands capital and accelerator access for ...

On March 26, 2026, traders mulled Wave's weak high-dose obesity results against the company's large market opportunity.

Wave Life Sciences has plummeted after two Wall Street firms cut price targets following updated trial data for the company's ...

W hile challenges persist in the short term, there are signs pointing toward long-term growth for life sciences, according to JLL’s 2024 Life Sciences Real Estate Perspective and Cluster Analysis. The ...

Dr. Mark Turco "will step down" from his role with the Hub Wednesday, March 11, to lead a medical device company.

When Hurricane Helene tore through Western North Carolina in September 2024, it didn't just uproot trees and wash out roads.

Anavex Life Sciences Corp. AVXL shares are tumbling on Wednesday after the company announced it has withdrawn its application ...